|
1
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: Models and concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rowehl RA, Crawford H, Dufour A, Ju J and
Botchkina GI: Genomic analysis of prostate cancer stem cells
isolated from a highly metastatic cell line. Cancer Genomics
Proteomics. 5:301–310. 2008.PubMed/NCBI
|
|
5
|
Abraham BK, Justenhoven C, Pesch B, Harth
V, Weirich G, Baisch C, Rabstein S, Ko YD, Brüning T, Fischer HP,
et al: Investigation of genetic variants of genes of the
hemochromatosis pathway and their role in breast cancer. Cancer
Epidemiol Biomarkers Prev. 14:1102–1107. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hill RP and Perris R: ‘Destemming’ cancer
stem cells. J Natl Cancer Inst. 99:1435–1440. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu QS, Rosenblatt K, Huang KL, Lahat G,
Brobey R, Bolshakov S, Nguyen T, Ding Z, Belousov R, Bill K, et al:
Vimentin is a novel AKT1 target mediating motility and invasion.
Oncogene. 30:457–470. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
An WF, Germain AR, Bishop JA, Nag PP,
Metkar S, Ketterman J, Walk M, Weiwer M, Liu X, Patnaik D, et al:
Discovery of potent and highly selective inhibitors of GSK3b.
2010.
|
|
9
|
Reya T and Clevers H: Wnt signalling in
stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pellicano F, Simara P, Sinclair A,
Helgason GV, Copland M, Grant S and Holyoake TL: The MEK inhibitor
PD184352 enhances BMS-214662-induced apoptosis in CD34+
CML stem/progenitor cells. Leukemia. 25:1159–1167. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li L, Bennett SA and Wang L: Role of
E-cadherin and other cell adhesion molecules in survival and
differentiation of human pluripotent stem cells. Cell Adh Migr.
6:59–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Satelli A and Li S: Vimentin in cancer and
its potential as a molecular target for cancer therapy. Cell Mol
Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawano K, Efferson CL, Peoples GE, Carter
D, Tsuda N, Murray JL and Ioannides CG: Sensitivity of
undifferentiated, high-TCR density CD8+ cells to
methylene groups appended to tumor antigen determines their
differentiation or death. Cancer Res. 65:2930–2937. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kruger NJ: The Bradford method for protein
quantitationMethods in Molecular Biology: Basic Protein and Peptide
Potocols. Chapter 32. Walker JM: Humana Press; Totowa, NJ: pp.
9–15. 1994
|
|
16
|
Gupta PB, Onder TT, Jiang G, Tao K,
Kuperwasser C, Weinberg RA and Lander ES: Identification of
selective inhibitors of cancer stem cells by high-throughput
screening. Cell. 138:645–659. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vinogradov S and Wei X: Cancer stem cells
and drug resistance: The potential of nanomedicine. Nanomedicine
(Lond). 7:597–615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Facompre N, Nakagawa H, Herlyn M and Basu
D: Stem-like cells and therapy resistance in squamous cell
carcinomas. Adv Pharmacol. 65:235–265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang SD, Yuan Y, Tang H, Liu XH, Fu CG,
Cheng HZ, Bi JW, Yu YW, Gong DJ, Zhang W, et al: Tumor cells
positive and negative for the common cancer stem cell markers are
capable of initiating tumor growth and generating both progenies.
PLoS One. 8:e545792013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jaggupilli A and Elkord E: Significance of
CD44 and CD24 as cancer stem cell markers: An enduring ambiguity.
Clin Dev Immunol. 2012:7080362012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Wang L, Pappan L, Galliher-Beckley A
and Shi J: IL-1β promotes stemness and invasiveness of
colon cancer cells through Zeb1 activation. Mol Cancer. 11:872012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang ZL, Fan ZQ, Jiang HD and Qu JM:
Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal
transition in human lung cancer cells via activating MEK-ERK
signaling. Carcinogenesis. 34:638–646. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xie G, Yao Q, Liu Y, Du S, Liu A, Guo Z,
Sun A, Ruan J, Chen L, Ye C and Yuan Y: IL-6-induced
epithelial-mesenchymal transition promotes the generation of breast
cancer stem-like cells analogous to mammosphere cultures. Int J
Oncol. 40:1171–1179. 2012.PubMed/NCBI
|
|
24
|
Hur EM and Zhou FQ: GSK3 signalling in
neural development. Nat Rev Neurosci. 11:539–551. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fisar Z and Hroudová J: Intracellular
signalling pathways and mood disorders. Folia Biol (Praha).
56:135–148. 2010.PubMed/NCBI
|
|
26
|
Zou Y, Liu FY, Wu J, Wan L, Fang SF, Zhang
ZY, Luo Y, Chen MH, Huang MZ, He M and Huang OP: Mutational
analysis of the RAS/RAF/MEK/ERK signaling pathway in 260 Han
Chinese patients with cervical carcinoma. Oncol Lett. 14:2427–2431.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xiong Y, Huang F, Li X, Chen Z, Feng D,
Jiang H, Chen W and Zhang X: CCL21/CCR7 interaction promotes
cellular migration and invasion via modulation of the MEK/ERK1/2
signaling pathway and correlates with lymphatic metastatic spread
and poor prognosis in urinary bladder cancer. Int J Oncol.
51:75–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Santarpia L, Lippman SM and El-Naggar AK:
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy.
Expert Opin Ther Targets. 16:103–119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Singh AM, Reynolds D, Cliff T, Ohtsuka S,
Mattheyses AL, Sun Y, Menendez L, Kulik M and Dalton S: Signaling
network crosstalk in human pluripotent cells: A Smad2/3-regulated
switch that controls the balance between self-renewal and
differentiation. Cell Stem Cell. 10:312–326. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gong K, Zhou F, Huang H, Gong Y and Zhang
L: Suppression of GSK3β by ERK mediates
lipopolysaccharide induced cell migration in macrophage through
β-catenin signaling. Protein Cell. 3:762–768. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sears R, Nuckolls F, Haura E, Taya Y,
Tamai K and Nevins JR: Multiple Ras-dependent phosphorylation
pathways regulate Myc protein stability. Genes Dev. 14:2501–2514.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dave B, Mittal V, Tan NM and Chang JC:
Epithelial-mesenchymal transition, cancer stem cells and treatment
resistance. Breast Cancer Res. 14:2022012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Y and Zhou BP: Epithelial-mesenchymal
transition in breast cancer progression and metastasis. Chin J
Cancer. 30:603–611. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiang J, Fu X, Ran W and Wang Z: Grhl2
reduces invasion and migration through inhibition of TGFβ-induced
EMT in gastric cancer. Oncogenesis. 6:e2842017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Phillips TM, McBride WH and Pajonk F: The
response of CD24(−/low)/CD44+ breast cancer-initiating
cells to radiation. J Natl Cancer Inst. 98:1777–1785. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Andarawewa KL, Erickson AC, Chou WS,
Costes SV, Gascard P, Mott JD, Bissell MJ and Barcellos-Hoff MH:
Ionizing radiation predisposes nonmalignant human mammary
epithelial cells to undergo transforming growth factor beta induced
epithelial to mesenchymal transition. Cancer Res. 67:8662–8670.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sineva GS and Pospelov VA: Inhibition of
GSK3beta enhances both adhesive and signalling activities of
beta-catenin in mouse embryonic stem cells. Biol Cell. 102:549–564.
2012. View Article : Google Scholar
|
